XOMAP
Closed
Xoma Corp
25.59
0.00 (0.00%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 25.59
Day's Range: 25.57 - 25.59
Send
sign up or login to leave a comment!
When Written:
24.2501
XOMA Corp is a biotechnology company that specializes in the discovery and development of therapeutic antibodies. The company was founded in 1981 and is headquartered in Emeryville, California. XOMA has a portfolio of proprietary and partnered programs that address a range of diseases, including cancer, infectious diseases, and inflammatory disorders. The company's lead product is gevokizumab, a monoclonal antibody that targets interleukin-1 beta, which is being developed for the treatment of multiple inflammatory and autoimmune diseases. XOMA has collaborations with several pharmaceutical companies, including Novartis, Pfizer, and Takeda, to develop and commercialize its products. The company has a market capitalization of approximately $225 million as of 2021.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!